Author/Authors :
Kuerten، نويسنده , , Stefanie and Pommerschein، نويسنده , , Giovanna and Barth، نويسنده , , Stefanie K. and Hohmann، نويسنده , , Christopher and Milles، نويسنده , , Bianca and Sammer، نويسنده , , Fabian W. and Duffy، نويسنده , , Cathrina E. and Wunsch، نويسنده , , Marie and Rovituso، نويسنده , , Damiano M. and Schroeter، نويسنده , , Michael and Addicks، نويسنده , , Klaus and Kaiser، نويسنده , , Claudia C. and Lehmann، نويسنده , , Paul V.، نويسنده ,
Abstract :
B cells are increasingly coming into play in the pathogenesis of multiple sclerosis (MS). Here, we screened peripheral blood mononuclear cells (PBMC) from patients with clinically isolated syndrome (CIS), MS, other non-inflammatory neurological, inflammatory neurological or autoimmune diseases, and healthy donors for their B cell reactivity to CNS antigen using the enzyme-linked immunospot technique (ELISPOT) after 96 h of polyclonal stimulation. Our data show that nine of 15 patients with CIS (60.0%) and 53 of 67 patients with definite MS (79.1%) displayed CNS-reactive B cells, compared to none of the control donors. The presence of CNS-reactive B cells in the blood of the majority of patients with MS or at risk to develop MS along with their absence in control subjects suggests that they might be indicative of a B cell-dependent subpopulation of the disease.
Keywords :
ELISpot , Autoimmunity , B cells , Blood , Multiple sclerosis
